Evidence map›Paper›PMID 31998537›Full record

ReviewJournal of radiosurgery and SBRT2019

Stereotactic body radiotherapy for benign spinal tumors: Meningiomas, schwannomas, and neurofibromas.

Lindsay Hwang, Christian C Okoye, Ravi B Patel, Arjun Sahgal, Matthew Foote, Kristin J Redmond, Christoph Hofstetter, Rajiv Saigal, Mahmud Mossa-Basha, William Yuh and 4 more

Open access · greenAbstract readReview
PubMed Full text at PMC
In one paragraph

Review in Journal of radiosurgery and SBRT, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. [Dosimetric effect of patient arm position on Cyberknife radiosurgery for spinal tumors].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2022
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Lindsay HwangDepartment of Radiation Oncology, University of Southern California, Los Angeles, CA, USA.
Christian C OkoyeDepartment of Radiation Oncology, St. Bernards Cancer Center, Jonesboro, AR, USA.
Ravi B PatelDepartment of Human Oncology, University of Wisconsin, Madison, WI, USA.
Arjun SahgalDepartment of Radiation Oncology, Sunnybrook Health Science Centre, University of Toronto, 2075 Bayview Ave, Toronto, ON, Canada.
Matthew FooteDepartment of Radiation Oncology, Sunnybrook Health Science Centre, University of Toronto, 2075 Bayview Ave, Toronto, ON, Canada.
Kristin J RedmondDepartment of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, 401 North Broadway, Suite 144, Baltimore, MD, USA.
Christoph HofstetterDepartment of Neurological Surgery, University of Washington, Seattle, WA, USA.
Rajiv SaigalDepartment of Neurological Surgery, University of Washington, Seattle, WA, USA.
Mahmud Mossa-BashaDepartment of Radiology, University of Washington, Harborview Medical Center, 325 9th Ave, Box 359728, Seattle, WA, USA.
William YuhDepartment of Radiology, University of Washington, Harborview Medical Center, 325 9th Ave, Box 359728, Seattle, WA, USA.
Nina A MayrDepartment of Radiation Oncology, University of Washington School of Medicine, Seattle, WA, USA.
Samuel T ChaoDepartment of Radiation Oncology, Cleveland Clinic, Lerner College of Medicine, 9500 Euclid Ave, CA-50, Cleveland, OH, USA.
Eric L ChangDepartment of Radiation Oncology, Norris Cancer Center and Keck School of Medicine at University of Southern California, 1441 Eastlake Ave, NOR G356, Los Angeles, CA, USA.
Simon S LoDepartment of Radiation Oncology, Princess Alexandra Hospital, University of Queensland, Woolloongabba, QLD, Australia.
University of Washington · USUniversity of Southern California · USUniversity of Wisconsin–Madison · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stereotactic body radiation therapy (SBRT) is a relatively new technology, and its use among patients with benign spinal tumors has limited prospective data. Similar to intracranial benign tumors treated successfully with SBRT, benign spinal tumors of the same histology can also develop, and SBRT may be an effective treatment alternative in inoperable or recurrent cases. Outcomes in patients with neurofibromatosis type 1, neurofibromatosis type 2, or schwannomatosis treated with SBRT have also been reported. Single institution reports have shown local control rates over 90% and improvement in clinical symptoms. The optimum dose and fractionation to maximize local control and minimize toxicity is unknown, with few incidences of radiation treatment-related toxicities. Given the location and benign nature of these tumors, careful management of dose to critical organs is essential. With continued follow-up, the optimum use of SBRT in patients with benign spinal tumors can be better defined.

Indexed as

benign tumorneurofibromaradiosurgerySBRTschwannomaspinal meningioma

Identifiers

PMID31998537
PMCPMC6774487
OpenAlexW2978042250

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.